The walking program showed similar overall adverse events to control but more lower-extremity symptoms, indicating the need to consider foot-ankle-knee-hip biomechanics in patients with vulnerable mechanics when prescribing walking.

Walking is not biomechanically neutral; it involves repetitive loading and potential asymmetry, so some patients may tolerate cycling or swimming better.

A clinical decision framework recommends walking as the first-line option for nonspecific, recurrent low back pain with good tolerance in the lower extremities; cycling is preferred for spinal stenosis, limb pain worsened by impact, leg-length discrepancy, or obesity; swimming or aquatic therapy suits low pain tolerance, osteoarthritis, instability, or a need for aerobic activity without pain.

Proposed mechanisms for benefit include progressive loading that drives tissue adaptation, neuromodulation and stress reduction, and behavioral advantages from ease of self-management.

The WalkBack trial, published in The Lancet in 2024, showed that a tailored, progressive walking program with education and coaching helped adults recently recovered from nonspecific low back pain by increasing weekly walking to about 130 minutes, reducing disabling recurrences and delaying new episodes, with likely cost-effectiveness.

Practical guidance involves starting activity below the irritation threshold, gradually increasing activity, and monitoring symptoms 24 to 48 hours after activity.

A survey of Australian chiropractors finds walking and walking groups feasible and commonly recommended, though knowledge gaps and inconsistent triage may limit effectiveness.

Walking benefits extend beyond back health to cardiovascular, metabolic, immune, and mental health, with outdoor walking offering mood benefits from daylight and nature.